Platelet Production and Function Flashcards

1
Q

what kind of cells do megakaryotes develop from?

A
  • hematopoietic stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where do hematopoietic stem cells reside?

A
  • in the bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

stem cell gives rise to

A
  • early bilineage progenitors that are able to undergo erythrocyte or megakaryocytic differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Meg-CFCs begin

A
  • endomitosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what happens in endomitosis

A
  • DNA replication continues

- neither nucleus nor cell undergoes division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does endomitosis produce?

A
  • a polyploid cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

after endomitosis, what happens with megakaryoctes?

A
  • they undergo cytoplasmic maturation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

process of cytoplasmic maturation

A
  • increase in size
  • fill with platelet-specific granules
  • expand content of cytoskeletal proteins
  • develop invaginated membrane system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

thrombopoietin function

A
  • the physiologically relevant regulator of platelet production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the TPO receptor

A
  • C-Mpl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

C-Mpl is located on

A
  • megakaryocytes

- platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

binding of TPO to its receptor does what

A
  • prevents apoptosis of megakaryocytes

- increases their number, size, and ploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

additional of TPO to CD34+ cells in culture results in

A
  • majority of cells becoming megakaryocytes

- shedding platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

synthesis of TPO is

A
  • static
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TPO is made in

A
  • the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

plasma TPO concentrations are regulated by

A
  • platelet production rates
  • platelet mass
  • MK mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

process of TPO regulation

A
  • platelets and MKs expression c-Mpl receptors that bind and clear TPO from circulation
  • thus regulate free TPO levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

integrins are

A
  • heterodimeric transmembrane molecules that cells use to both bind to and respond to extracellular matrix proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

integrins composed of

A
  • alpha and beta subunits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

integrins link

A
  • extracellular matrix

- intracellular cytoskeleton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

clustering of integrins leads to

A
  • signaling into the cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

signaling in the cell also causes

A
  • activation of other integrins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

major platelet glycoproteins that are integrins

A
  • a2B1

- A2bB3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

another name for a2B1

A
  • GPIa-IIa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
GPIa-IIa binds
- collagen
26
another name for a2bB3
- GPIIb-IIIa
27
GPIIb-IIIa binds
- fibrinogen
28
platelet glycoproteins that are not integrins
- GP Ib-IX-V | - GPVI
29
GP Ib-IX-V binds
- von Willebrand factor
30
GPVI activates
- platelets by binding to collagen
31
platelet plug formation
- adhesion - activation - aggregation - secretion
32
adhesion
- platelets stick to injured vessel wall via GP Ib-IX-V (1b-9-5) binding to vWF
33
activation
- resting platelets come into contact with agonists that bind receptors - signaling occurs - platelets change shape, secrete, and activate their GP IIb-IIIa integrins
34
aggregation
- platelets stick to each other via fibrinogen bridges binding to activated GP IIb-IIIa
35
secretion
- platelets release granular contents and potentiate clotting
36
platelet activators examples
- thrombin - thromboxane - collagen - ADP
37
thrombin receptor
- PAR-1
38
type of receptor that PAR-1 is
- GPCR
39
what is the ligand of PAR-1
- it's own proteolyzed N-terminus
40
importance of thrombin
- most potent platelet agonist
41
how is thromboxane produced
- arachidonic acid -> TxA2 | - by COX1
42
COX1 reversibly blocked by
- NSAIDS
43
COX1 irreversibly blocked by
- aspirin
44
thromboxane receptor - type of receptor
- GPCR
45
what keeps the platelets from sticking to normal endothelium?
- nitric oxide - ecto-ADPase - prostacyclin
46
nitric oxide
- vasodilator
47
Ecto-ADPase
- chews up ADP to prevent platelet activation
48
how is prostacyclin produced
- arachadonic acid -> prostacyclin | - via COX-1 and COX-2
49
prostacyclin
- vasodilator | - inhibits platelet activation
50
membrane of platelets after activation why?
- turned inside out | - so the negative charges are on the outside
51
what anchors themselves to the now neg charged platelet membrane?
- coagulation proteins with gamma carboxyl groups
52
qualitative platelets disorders diagnosed by
- a prolonged bleeding time | - or PFA 100 time
53
PT in platelet qualitative disorders
- normal
54
PTT in platelet qualitative disorders
- normal
55
TT in platelet qualitative disorders
- normal
56
DDX of qualitative platelet disorders
- congenital | - acquired
57
DDx of congenital qualitative platelet disorders
- Bernard-Soulier | - Glanzmann's thrombaesthenia
58
Bernard-Soulier defect in
- Ib-IX on platelet surface
59
result of Bernard-Soulier
- no adhesion
60
Ddx of acquired qualitative platelet disorders
- uremia - drugs - herbs - myeloproliferative diseases
61
drugs that induce qualitative platelet disorders
- ASA | - NSAIDS
62
symptoms of platelet dysfunction
- same defects as primary hemostasis - petechiae - mucocutaneous bleeding
63
mucocutaneous bleeding is
- oozing and bruising
64
mucocutaneous bleeding is NOT
- hematomas | - bleeding into joints
65
abnormal platelet activation results in
- arterial occlusion
66
with splenic enlargement and when platelets go there to hang out, what happens with the TPO levels?
- they stay the same
67
collagen receptors
- GP Ia/IIa | - GP VI
68
adhesion to collagen mediated by
- GPIa/IIa
69
GPVI acts in complex with to cause
- FcR gamma | - platelet activation
70
ADP released by
- damaged RBCs
71
ADP secreted by
- activated platelets
72
ADP receptors
- P2Y12 | - P2Y1
73
type of receptor P2Y12, P2Y1
- GPCR
74
P2Y12 target of
- anti platelet drugs
75
Glanzmann's defect in
- IIb/IIIa
76
result of Glanzmann's
- no aggregation